NCT03440385 · Interventional trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Overall registry status Completed
Phase 3
Conditions Crohn Disease
Delaware Valley sites
- University of Pennsylvania Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory